| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 326.966 | 259.887 | 138.595 | 7.802 | 8.343 | 8.992 | 13.592 | 14.299 | 14.959 | 14.788 |
| Total Income - EUR | 330.066 | 261.834 | 282.188 | 8.925 | 9.815 | 11.160 | 16.755 | 17.800 | 15.052 | 20.208 |
| Total Expenses - EUR | 328.532 | 249.501 | 143.614 | 8.018 | 2.132 | 17.925 | 16.505 | 16.967 | 14.395 | 14.844 |
| Gross Profit/Loss - EUR | 1.535 | 12.332 | 138.573 | 907 | 7.683 | -6.765 | 251 | 832 | 657 | 5.364 |
| Net Profit/Loss - EUR | 1.020 | 10.614 | 135.786 | 640 | 7.388 | -7.083 | -242 | 309 | -287 | 3.717 |
| Employees | 5 | 5 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Kamill Farmacie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 66.508 | 63.001 | 59.054 | 73.323 | 183.903 | 289.280 | 271.658 | 258.865 | 246.185 | 466.175 |
| Current Assets | 85.040 | 74.552 | 99.129 | 71.349 | 64.088 | 5.240 | 3.513 | 1.565 | 1.583 | 9.806 |
| Inventories | 62.601 | 56.623 | 0 | 0 | 573 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 13.514 | 6.430 | 307 | 115 | 40 | 3.270 | 2.827 | 813 | 1.181 | 154 |
| Cash | 8.925 | 11.500 | 98.822 | 71.234 | 63.474 | 1.970 | 686 | 753 | 402 | 9.652 |
| Shareholders Funds | 101.157 | 93.266 | 152.292 | 136.341 | 246.743 | 229.607 | 224.274 | 225.279 | 223.419 | 459.104 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 50.538 | 44.455 | 5.892 | 8.331 | 1.248 | 64.912 | 50.897 | 35.152 | 24.349 | 15.305 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.573 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Kamill Farmacie Srl